Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ05
- Pharmacological subgroupJ05A
- Chemical subgroupJ05AGNon-nucleoside reverse transcriptase inh
- Chemical substanceJ05AG05Rilpivirine
Where it is registered
Each register with its number of medicines and a few of them.
United States
FDA · 13 medicines
- Edurant25MG BASE · tablet · Janssen Prods
- Edurant Ped2.5MG BASE · tablet, for suspension · Janssen Prods
- Rilpivirine Hydrochloride25MG BASE · tablet · Somerset Theraps LLC
- Cabenuva Kit400MG/2ML (200MG/ML); 600MG/2ML, 600MG/3ML (200MG/ML); 900MG/3ML · suspension, extended release · Viiv Hlthcare
Netherlands
CBG-MEB · 7 medicines



